CRISPR Therapeutics
CRSP
#3209
Rank
โ‚ฌ4.18 B
Marketcap
43,40ย โ‚ฌ
Share price
0.92%
Change (1 day)
33.89%
Change (1 year)

Annual Reports (10-K)

Latest form 10-K annual reports for CRISPR Therapeutics CIK: 0001674416

Thumbnail CRISPR Therapeutics 10-K Annual Report

10-K Annual Report 2026-02-12

Language: English

View Annual Report (10-K)
Thumbnail CRISPR Therapeutics 10-K Annual Report

10-K Annual Report 2025-02-11

Language: English

View Annual Report (10-K)
Thumbnail CRISPR Therapeutics 10-K Annual Report

10-K Annual Report 2024-02-21

Language: English

View Annual Report (10-K)
Thumbnail CRISPR Therapeutics 10-K Annual Report

10-K Annual Report 2023-02-21

Language: English

View Annual Report (10-K)
Thumbnail CRISPR Therapeutics 10-K Annual Report

10-K Annual Report 2022-02-15

Language: English

View Annual Report (10-K)
Thumbnail CRISPR Therapeutics 10-K Annual Report

10-K Annual Report 2021-02-16

Language: English

View Annual Report (10-K)
Thumbnail CRISPR Therapeutics 10-K Annual Report

10-K Annual Report 2020-02-12

Language: English

View Annual Report (10-K)
Thumbnail CRISPR Therapeutics 10-K Annual Report

10-K Annual Report 2019-02-25

Language: English

View Annual Report (10-K)
Thumbnail CRISPR Therapeutics 10-K Annual Report

10-K Annual Report 2018-03-08

Language: English

View Annual Report (10-K)
Thumbnail CRISPR Therapeutics 10-K Annual Report

10-K Annual Report 2017-03-10

Language: English

View Annual Report (10-K)